Early Goal-Directed Therapy Utilizing Transpulmonary Thermodilution and Severe Burn Injury

CompletedOBSERVATIONAL
Enrollment

66

Participants

Timeline

Start Date

August 7, 2021

Primary Completion Date

November 30, 2021

Study Completion Date

January 20, 2022

Conditions
Burns
Interventions
OTHER

Control group: Patients being admitted when The advancement of transpulmonary thermodilution(TPTD) device was unavailable.

The control group included patients being admitted when TPTD device was unavailable; and relatively stable patients without the need for TPTD. The adequacy of fluid resuscitation in the control group was monitored by traditional monitoring parameters including vital signs and hourly urine output.

OTHER

Study group: TPTD device was implemented for monitoring.

TPTD device was implemented for monitoring; the inclusion criteria included patients suffering from 2nd degree burn greater than 40% TBSA; a combined 2nd to 3rd degree burn greater than 30% TBSA; or patients with inhalation injury despite the burned surface area.

Trial Locations (1)

83301

Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City

All Listed Sponsors
lead

Chang Gung Memorial Hospital

OTHER

NCT05420610 - Early Goal-Directed Therapy Utilizing Transpulmonary Thermodilution and Severe Burn Injury | Biotech Hunter | Biotech Hunter